Case study

Showing 9 posts of 9 posts found.

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

February 20, 2023
Business Services

PARIS, FRANCE, STRICTLY EMBARGOED until 11.00pm CET, 13 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, …

Booklet labels or Just-In-Time labelling: A question of standards

September 7, 2017
Business Services, Manufacturing and Production Faubel, Labelling, packaging

Pharmaceutical companies are multiplying their efforts to establish just-in-time labeling. For Anthony Morrow, Business Development Manager Northern Europe at Faubel, …

High demands: Requirements on the labelling of pharmaceutical products are growing continuously

September 7, 2017
Business Services, Manufacturing and Production Faubel, Labelling

There are numerous criteria to be met by label manufacturers. In this context, topics such as patient compliance and smart …

Navigating the challenges of health technology assessment

May 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI, Global Pricing Innovations

In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …

Quotient Clinical receives MHRA Supplementary Accreditation

February 26, 2010
Research and Development Quotient

 This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform …

Systematic Review

December 7, 2009
Research and Development

Therapy background

Full service

December 7, 2009
Research and Development

Therapy background

Latest content